Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Ornbjerg, Lykke; Brahe, Cecilie; Askling, Johan; Ciurea, Adrian; Mann, Herman; ÖNEN, FATOŞ; Kristianslund, Eirik; Nordstrom, Dan; Santos, Maria; Codreanu, Catalin; Gomez-Reino, Juan; Rotar, Ziga; Gudbjornsson, Bjorn; Di Giuseppe, Daniela; Nissen, Michael; Pavelka, Karel; Birlik, AHMET; Kvien, Tore; Eklund, Kari; Barcelos, Anabela; Ionescu, Ruxandra; Sanchez-Piedra, Carlos; Tomsic, Matija; Geirsson, Arni; Loft, Anne; van der Horst-Bruinsma, Irene; Jones, Gareth; Iannone, Florenzo; Hyldstrup, Lise; Krogh, Niels; Hetland, Merete; Ostergaard, Mikkel

doi:10.1136/annrheumdis-2019-215427

Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Copy For Citation

Ornbjerg L. M., Brahe C. H., Askling J., Ciurea A., Mann H., ÖNEN F., ...More

ANNALS OF THE RHEUMATIC DISEASES, vol.78, no.11, pp.1536-1544, 2019 (SCI-Expanded)

Publication Type: Article / Article
Volume: 78 Issue: 11
Publication Date: 2019
Doi Number: 10.1136/annrheumdis-2019-215427
Journal Name: ANNALS OF THE RHEUMATIC DISEASES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1536-1544
Dokuz Eylül University Affiliated: Yes

Abstract

Objective To study drug retention and response rates in patients with axial spondyloarthritis (axSpA) initiating a first tumour necrosis factor inhibitor (TNFi).